MediWound Planning $100M IPO On Nasdaq

February 3, 2014 | Israeli company MediWound, which develops treatments for burns and wounds, has announced that it has filed a draft prospectus for an offering on Nasdaq. The company will hold the IPO at a company value of $400 million (before money) and attempt to raise $100 million. The majority shareholder of the company is Clal Biotechnology.